Solutions For Anti-Cancer Therapy, Prevention of Cancer Disease

Solutions for Anti-cancer Therapy CapitalBio

With the rapid expansion of the demand for advanced diagnosis and treatment, prevention, and early screening, liquid biopsy based on blood, saliva, or other body fluids has been widely recognized in technology and market for its non-invasive and repeatable sampling characteristics. CapitalBio Technology provides a comprehensive Anti-cancer solution to realize the full management of cancer patients from prevention, early screening, prognosis assessment, medication guidance, treatment effect monitoring and recurrence detection. The anti-cancer solutions of CapitalBio Technology cover all stages of cancer development, from diagnosis to treatment to prognosis.

Types Of Solutions For Anti-cancer Therapy

Precise Diagnosis and Treatment for Brain Cancer

This test comprehensively detects the molecular signatures of relevant tumor drugs approved by NMPA/FDA, as well as the genes related to typing, diagnosis, prognosis and medication in NCCN/CSCO/WHO guidelines, brain tumor research and related clinical trials.

Targeted Medication Guidance for Lung Cancer

This test detects SNV、InDel、CNV and gene rearrangement of 12 genes closely related to lung cancer, it is mainly used for lung cancer targeted medication guidance and drug resistance monitoring.

Targeted Medication Guidance for Colorectal Cancer

The test detects 14 genes closely related to colorectal cancer, it is mainly used for colorectal cancer targeted drug guidance and drug resistance monitoring.

Individualized Medication Guidance for Gastrointestinal Cancer

This test detects 84 genes related to gastrointestinal cancer.

Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic]

This test detects somatic and germline mutations in the BRCA1 and BRCA2 genes, provide information to guide PARP inhibitor therapy in breast & ovarian cancer.

Individualized Medication Guidance for Breast Cancer

This test detects 348 genes, involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.

Individualized Medication Guidance for Gynecologic Cancer

This test detects 348 genes, involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for gynecologic cancer patients.

Breast Cancer Prognosis Assessment

This test can aid in the development of breast cancer treatment plans and avoid conditions such as undertreatment or overtreatment.

Genetic Testing for Hereditary Breast/Ovarian Cancer(BRCA1/2)

This test detects the entire coding region of BRCA1/BRCA2 genes, provides information on preventive guidance、 medication guidance and prognostic assessment.

Individualized Medication Guidance for Prostate Cancer

This test detects 346 genes, involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.

Genetic Testing for Blood Cancer

This test can detect 232 genes associated with blood cancers, covers all types of leukemia - AML/ALL/CML/CLL/MDS/MPN and various lymphomas.

Genetic Testing of 18 Hereditary Cancer

This test can provide risk assessment in high-risk groups with a family history by detecting gene mutations in the entire coding region and splice region of 64 genes associated with 18 hereditary tumors at one time.

Individualized Chemotherapy Drugs For Cancers (10 Genes)

This test can detect gene polymorphisms related to 13 common chemotherapeutic drugs, assist clinicians in formulating individualized chemotherapy medication plans.

Individualized Medication Guidance for Cancer (118 Genes)

This test detects 136 genes, provides the correlation between gene mutations and targeted drugs and chemotherapy drugs based on clinical data, and assists doctors to formulate personalized medication guidance for patients.

Individualized Medication Guidance for Cancer (800 Genes)

This test detects 800 genes, helping doctors formulate professional and individualized treatment plans for patients.

What is Targeted Therapy?

Targeted therapy is a treatment method at the cellular and molecular level that targets a well-defined cancer-causing site (the site can be a protein molecule inside a tumor cell or a gene segment). Corresponding therapeutic drugs can be designed. When the drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing the tumor cells to specifically die without affecting the normal tissue cells around the tumor. Therefore, molecular targeted therapy is also known as "Bio Missile".

Molecular targeted drugs of different categories target different gene targets. Through driver gene detection, it can be found whether there are corresponding gene targets, so as to select suitable targeted drugs for patients in a targeted manner.